TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Idexx Laboratories Norge AS
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
9,334
|
8,256
|
76,460 |
Financial expenses |
5
|
0
|
1 |
Earnings before taxes |
1,851
|
1,561
|
1,264 |
Total assets |
20,726
|
17,584
|
22,011 |
Current assets |
20,487
|
17,265
|
21,500 |
Current liabilities |
10,446
|
8,118
|
13,262 |
Equity capital |
9,828
|
8,944
|
8,163 |
- share capital |
80
|
85
|
89 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
47.4%
|
50.9%
|
37.1% |
Turnover per employee | |||
Profit as a percentage of turnover |
19.8%
|
18.9%
|
1.7% |
Return on assets (ROA) |
9.0%
|
8.9%
|
5.7% |
Current ratio |
196.1%
|
212.7%
|
162.1% |
Return on equity (ROE) |
18.8%
|
17.5%
|
15.5% |
Change turnover |
1,585
|
-64,188
|
11,400 |
Change turnover % |
20%
|
-89%
|
18% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.